M RE6 (Ropinirole hydrochloride extended-release 6 mg)

Pill imprint M RE6 has been identified as Ropinirole hydrochloride extended-release 6 mg.

Ropinirole is used in the treatment of restless legs syndrome; periodic limb movement disorder; parkinson's disease; tardive dyskinesia and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Ropinirole 6 mg is not a controlled substance under the Controlled Substance Act (CSA).

Ropinirole hydrochloride extended-release

Imprint:

M RE6

Strength:

6 mg

Color:

White

Shape:

Round

Availability:

Prescription only

Drug Class:

Dopaminergic antiparkinsonism agents

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Manufacturer:

Mylan Pharmaceuticals Inc.

National Drug Code (NDC):

00378-4092

Inactive Ingredients:

lactose anhydrous
ferrosoferric oxide
silicon dioxide
ethylcelluloses
FD&C Red No. 40
FD&C Yellow No. 6
hypromelloses
magnesium stearate
microcrystalline cellulose
propylene glycol
FD&C Blue No. 2

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.